在中度至重度喘患者中,杜皮卢马布维持了肺功能改善
Alberto Papi1, Mario Castro2, Jonathan Corren3
1Respiratory Medicine Unit, University of Ferrara, S. Anna University Hospital, Ferrara, Italy.
Respiratory medicine
|January 25, 2024
概括
在中度至重度喘患者中,dupilumab显著改善并维持了长达三年的肺功能. 最初接受安慰剂的患者在开始使用dupilumab后也表现出迅速的肺功能增长.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- TRAVERSE研究 (NCT02134028) 是一个第三阶段的开放性扩展研究,评估了12岁以上的喘患者的dupilumab.
- 这项分析重点是中度至重度喘患者,其2型生物标志物 (乙素≥150细胞·μL−1或FeNO≥25ppb) 高.
研究的目的:
- 评估dupilumab在喘中的长期安全性和有效性.
- 为了评估TRAVERSE研究中多个肺功能参数在2年多的dupilumab治疗中发生的变化.
主要方法:
- 支气管扩张前1秒内强制呼吸量 (FEV1),强制生命能力 (FVC) 和强制呼吸流量 (FEF25-75%) 的分析.
- 支气管扩展前后FEV1/FVC比率和FEV1斜率的评估.
- 在TRAVERSE研究中,对基因研究基线 (PSBL) 和直到96周的数据进行了描述性统计分析.
主要成果:
- 杜皮卢马布从QUEST研究到TRAVERSE研究中持续改善了FEV1,FVC和FEF25-75%.
- 在TRAVERSE中从安慰剂转换为dupilumab的患者经历了快速的肺功能改善.
- 在dupilumab/dupilumab和安慰剂/dupilumab组中,在48周和96周观察到PSBL前支气管扩展剂FEV1的平均增加.
结论:
- 杜皮卢马布在螺旋计肺功能测量中提供了持续改善,长达3年.
- 在先前接受安慰剂治疗的患者中,启动dupilumab导致肺功能迅速增强.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
300
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
300
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
01:26COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:23Inhaled Medications
269
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
269